Genetic Technologies Buy Hold or Sell Recommendation
| GENEDelisted Stock | USD 0.77 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Genetic Technologies is 'Not Rated'. Macroaxis provides Genetic Technologies buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GENE positions.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Note, we conduct extensive research on individual companies such as Genetic and provide practical buy, sell, or hold advice based on investors' constraints. Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Genetic |
Execute Genetic Technologies Buy or Sell Advice
The Genetic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genetic Technologies. Macroaxis does not own or have any residual interests in Genetic Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genetic Technologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Genetic Technologies Trading Alerts and Improvement Suggestions
| Genetic Technologies is not yet fully synchronised with the market data | |
| Genetic Technologies generated a negative expected return over the last 90 days | |
| Genetic Technologies has some characteristics of a very speculative penny stock | |
| Genetic Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.66 M. Net Loss for the year was (12.02 M) with profit before overhead, payroll, taxes, and interest of 6.01 M. | |
| Genetic Technologies currently holds about 11.74 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. |
Genetic Technologies Returns Distribution Density
The distribution of Genetic Technologies' historical returns is an attempt to chart the uncertainty of Genetic Technologies' future price movements. The chart of the probability distribution of Genetic Technologies daily returns describes the distribution of returns around its average expected value. We use Genetic Technologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genetic Technologies returns is essential to provide solid investment advice for Genetic Technologies.
| Mean Return | 0.02 | Value At Risk | 0.00 | Potential Upside | 1.35 | Standard Deviation | 0.99 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genetic Technologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 10000 shares by Hennessey Robert J of Genetic Technologies at 5.5003 subject to Rule 16b-3 [view details]
Genetic Technologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genetic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Genetic Technologies Buy or Sell Advice
When is the right time to buy or sell Genetic Technologies? Buying financial instruments such as Genetic Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Genetic Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities Thematic Idea Now
Utilities
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Genetic Stock
If you are still planning to invest in Genetic Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetic Technologies' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |